Real-time AI-scored market movers with ± impact ratings from -100 to +100. Latest: Gene Munster Argues OpenAI Is 'Undervalued' Even At $830 Billion As Losses Mount And Big Tech Doubles Down: 'Mind-Numbing Reality Of AI's Potential' (Impact: +70). TezNewz delivers instant financial news analysis through Discord with sector-specific insights and comprehensive market intelligence.
Financial News with AI Impact Scores
Get real-time financial news with AI-powered impact analysis delivered through Discord
Today's Market Overview
TezNewz delivers AI-scored financial news with impact ratings from -100 to +100. Latest stories cover Technology, Consumer Cyclical, Healthcare sectors. Top impact story: "Gene Munster Argues OpenAI Is 'Undervalued' Even At $830 Billion As Losses Mount And Big Tech Doubles Down: 'Mind-Numbing Reality Of AI's Potential'" with +70 impact score.
Join our Discord community for real-time alerts and discussions.
Gene Munster from Deepwater Asset Management argues that OpenAI's rumored $830 billion valuation may still be undervalued, despite the company facing projected cumulative losses of $100 billion to $150 billion between 2025 and 2029. He highlights OpenAI's growth trajectory, estimating revenue could rise from $4 billion in 2024 to $70 billion in 2027, and notes that ChatGPT has approximately 900 million weekly active users. Additionally, OpenAI is reportedly preparing for a potential IPO that could value the company at up to $1 trillion.
Ford Motor Co. has announced a recall of over 270,000 electric and hybrid vehicles in the U.S. due to a potential roll-away risk associated with the integrated park module. The recall affects certain 2022–2026 F-150 Lightning BEV models, 2024–2026 Mustang Mach-E vehicles, and 2025–2026 Maverick models. This recall adds to Ford's over 135 recalls issued in 2025, as the company refocuses on higher-return opportunities and halts production of the electric F-150 Lightning.
President Donald Trump announced agreements with nine major pharmaceutical companies, including Bristol Myers Squibb, Gilead, and Merck, to lower drug prices for Medicaid and cash payers, aligning U.S. costs with those in other wealthy nations. The deal includes most-favored-nation pricing and a commitment to launch new drugs at prices no higher than those in other countries. The companies have pledged over $150 billion in U.S. R&D and manufacturing investments, with Merck committing more than $70 billion. Additionally, firms will receive three-year tariff exemptions in exchange for these commitments.
The Delaware Supreme Court has reinstated Elon Musk's 2018 Tesla compensation plan, which is now valued at approximately $139 billion, reversing a previous lower court ruling. The court stated that voiding the deal was inequitable and left Musk uncompensated for his efforts over six years. If Musk exercises all stock options from this plan, his stake in Tesla could increase from 12.4% to about 18.1%. Tesla shares closed at $481.20, down 0.45%, but rose 0.30% in after-hours trading.
Medtronic's MiniMed Group has filed for a U.S. initial public offering (IPO) as part of its separation from Medtronic. For the six months ending October 24, MiniMed reported a net loss of $21 million on net sales of $1.48 billion, compared to a net loss of $23 million on sales of $1.3 billion in the same period last year. Medtronic will retain at least 80.1% of the voting stock post-IPO and plans to use proceeds to repay intercompany debt. The IPO will be underwritten by Goldman Sachs, BofA Securities, Citigroup, and Morgan Stanley, and MiniMed intends to list on Nasdaq under the symbol 'MMED'.
Starbucks Corp. has appointed Anand Varadarajan as its new Chief Technology Officer, effective January 19, 2024. Varadarajan, who previously worked at Amazon for nearly 19 years, takes over following the departure of former CTO Deb Hall Lefevre amid a restructuring plan. Starbucks has recently reported its first quarter of gains in comparable sales after a challenging period and is currently facing a 4.2% decline in stock price this year, trading at $88.33.
